APTOSE BIOSCIENCES INC (APTO) Stock Cash Flow
NASDAQ:APTO - Nasdaq - CA03835T3091 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -35.80M | -51.21M | -41.82M | -65.35M | -55.24M | |||
| Depreciation Amortization | 46.00K | 88.00K | 120.00K | 150.00K | 152.00K | |||
| Change In Working Capital | -3.41M | 2.40M | 3.77M | 961.00K | -799.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 1.99M | 4.12M | 5.61M | 20.94M | 21.99M | |||
| OPERATING CASH FLOW | -37.18M | -44.59M | -32.32M | -43.30M | -33.89M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -29.00K | -24.00K | -212.00K | -79.00K | |||
| Other Investing Activity | 1.96M | 9.99M | 30.09M | -35.00M | 12.71M | |||
| INVESTING CASH FLOW | 1.96M | 9.96M | 30.07M | -35.21M | 12.63M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 17.63M | 6.91M | 116.00K | 226.00K | 58.98M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | -168.00K | |||
| FINANCING CASH FLOW | 27.46M | 6.91M | 116.00K | 226.00K | 58.81M | |||
| Exchange Rate Effect | -1.00K | 2.00K | -4.00K | 7.00K | 7.00K | |||
| CHANGE IN CASH | -7.76M | -27.72M | -2.14M | -78.28M | 37.55M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -37.18M | -44.59M | -32.32M | -43.30M | -33.89M | |||
| Capital Expenditure | N/A | -29.00K | -24.00K | -212.00K | -79.00K | |||
| FREE CASH FLOW | -37.18M | -44.62M | -32.35M | -43.52M | -33.97M | |||
All data in USD